Cyanotech

Cyanotech Debt / Assets

The Debt-to-Assets Ratio of Cyanotech (CYAN) as of Nov 4, 2026 is 0.52. In the previous year, Debt-to-Assets Ratio was 0.49 — a change of 6.48% (higher).

Debt / Assets

0.52

YoY

6.48%

Last updated:

Debt-to-Assets Ratio of Cyanotech is 2026 0.52 . Debt-to-Assets Ratio of Cyanotech was 2025 0.49 . It decreases by 6.48% higher compared to the previous year.

The Cyanotech Debt / Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt / Assets
Date
Debt / Assets
Jan 1, 2019
0.27 USD
Jan 1, 2020
0.40 USD
Jan 1, 2021
0.35 USD
Jan 1, 2022
0.28 USD
Jan 1, 2023
0.38 USD
Jan 1, 2024
0.43 USD
Jan 1, 2025
0.49 USD
Jan 1, 2026
0.52 USD
The Cyanotech Debt / Assets history
YEARDebt / AssetsYoY
0.52+6.48%
0.49+13.38%
0.43+15.59%
0.38+33.78%
0.28-20.41%
0.35-10.81%
0.40+44.32%
0.27+17.24%
0.23-8.90%
0.26+4.23%
0.25+42.45%
0.17-4.18%
0.18—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cyanotech Stock analysis

What does Cyanotech do? Cyanotech Corp develops and commercializes natural products from microalgae, focusing on Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement providing energy, immune support, cardiovascular benefits, and antioxidant carotenoids. Hawaiian BioAstin supports inflammatory response, skin health, eye health, and joint health as a dietary antioxidant. The company cultivates two microalgal species in Hawaii, producing natural astaxanthin and spirulina products. Finished products are manufactured in Hawaii and California, with the firm targeting health-conscious consumers seeking natural supplements. The company's revenue streams come from direct sales of Hawaiian Spirulina Pacifica and Hawaiian BioAstin to consumers through retail channels and online platforms. These products are sold under their respective brand names, with no additional brands or product lines mentioned. The firm's primary market segment consists of individuals interested in dietary supplements for wellness, immune support, and natural health solutions, emphasizing the Hawaiian origin and natural sourcing of their products. Cyanotech Corp's business model relies on the cultivation of microalgae in Hawaii, where it produces raw materials for its product lines. The manufacturing of finished products occurs in Hawaii and California, ensuring quality control and adherence to natural product standards. The company's focus on natural, health-oriented products appeals to a specific demographic of health enthusiasts and consumers prioritizing natural ingredients in their wellness routines. Cyanotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cyanotech stock

Debt-to-Assets Ratio of Cyanotech is 0.52 in 2026.

Debt-to-Assets Ratio of Cyanotech changed from 0.49 to 0.52, representing a 6.48% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt-to-Assets Ratio Cyanotech since 2006 – with annual values, charts, and detailed analysis.

The Debt-to-Assets ratio measures what percentage of a company's assets are financed through debt. Higher ratios indicate greater financial risk.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt-to-Assets Ratio's Cyanotech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Cyanotech

All Key Metrics — Cyanotech